Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a complex and challenging condition characterized by extreme fatigue that doesn't improve with rest and worsens with physical or mental activity. Diagnosing CFS can be difficult as its symptoms overlap with many other conditions.
At DNA Labs UAE, a specialized test is available to assist in the diagnosis of Chronic Fatigue Syndrome. This test aims to identify specific biomarkers and genetic predispositions associated with CFS, offering a more targeted approach to understanding the patient's condition. The test is priced at 820 AED, making it accessible for individuals seeking insights into their unexplained fatigue and related symptoms.
The process at DNA Labs UAE involves a simple and non-invasive procedure, ensuring a comfortable experience for the patient. After the test, comprehensive results are provided, which can be crucial for the healthcare provider in formulating a personalized treatment plan. This test is a valuable tool in the diagnostic process, offering hope and direction for those affected by this debilitating syndrome.
The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 2 Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify specific genetic mutations associated with CLL. This test plays a crucial role in understanding the genetic landscape of an individual's leukemia, which can significantly influence treatment decisions and prognostic assessments. By analyzing the DNA from a patient's blood or bone marrow sample, the panel screens for a range of mutations known to be involved in CLL pathogenesis.
The cost of the CLL Mutations Detection Panel 2 Test is 820 AED. The price reflects the comprehensive nature of the test, as it encompasses a broad spectrum of genetic markers that are crucial for tailoring patient-specific therapeutic strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a pivotal resource for healthcare providers in the management of CLL, offering insights that can lead to more personalized and effective treatment plans.
The "Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 1 Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify specific genetic mutations associated with CLL. This test plays a crucial role in the precise diagnosis and management of CLL, a type of cancer characterized by the accumulation of abnormal lymphocytes in the blood and bone marrow. By analyzing the patient's DNA, the test can detect mutations that are known to influence the disease's behavior, prognosis, and response to treatment. The cost of the test is 820 AED, making it a valuable tool for healthcare professionals in tailoring personalized treatment plans for CLL patients, enhancing the effectiveness of therapy, and potentially improving patient outcomes.
The Des-Gamma Carboxy Prothrombin (DCP), also known as Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), Serum Test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to measure the levels of Des-Gamma Carboxy Prothrombin in the blood, which is a non-functional precursor of prothrombin. Elevated levels of DCP/PIVKA-II are often associated with liver dysfunction and can be particularly indicative of hepatocellular carcinoma (HCC), a common type of liver cancer.
The test is crucial for individuals at risk of liver diseases or for those being monitored for the progression or treatment response of liver cancer. By detecting abnormal levels of DCP, healthcare providers can make more informed decisions regarding the diagnosis, prognosis, and treatment strategies for affected patients.
At DNA Labs UAE, the Des-Gamma Carboxy Prothrombin (DCP/PIVKA-II) Serum Test is offered at a cost of 820 AED. The facility ensures accurate and reliable results, utilizing state-of-the-art technology and methodologies to support patient care and disease management.
The Hypogonadism Panel for Females Test is a comprehensive diagnostic assessment aimed at evaluating the hormonal balance related to the female reproductive system, specifically focusing on conditions associated with hypogonadism. This condition is characterized by the underproduction of hormones necessary for sexual development and reproductive function. The panel typically includes tests for measuring levels of various hormones such as estrogen, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and sometimes prolactin, among others. These hormones play crucial roles in regulating menstrual cycles, ovulation, and overall reproductive health.
Conducted at DNA Labs UAE, a facility known for its advanced diagnostic services and accuracy, the test is priced at 820 AED. This cost is reflective of the comprehensive nature of the assessment and the precision with which the lab conducts its analyses. Patients seeking this test may be experiencing symptoms such as irregular menstrual cycles, infertility, reduced libido, or other signs pointing towards hormonal imbalances or reproductive health issues. The results from this panel can help healthcare providers diagnose the underlying causes of these symptoms and develop an appropriate treatment plan to address them.
The Hypogonadism Panel for Males Test, offered at DNA Labs UAE for 820 AED, is a comprehensive diagnostic evaluation designed to assess the functioning of the male reproductive system by measuring the levels of specific hormones in the blood. This panel typically includes tests for testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), among others, which are crucial in determining the presence of hypogonadism—a condition characterized by the body's inability to produce adequate levels of testosterone. Testosterone is essential for male development, reproductive function, and the maintenance of muscle mass and bone density. Identifying abnormalities in hormone levels through this panel can help in diagnosing various conditions related to hypogonadism, guiding appropriate treatment strategies. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test ensures accurate and reliable results, contributing significantly to the management of male reproductive health.
The "Immunohistochemistry Digital Breast Cancer Panel 1 Test," available at DNA Labs UAE, is a cutting-edge diagnostic tool designed to provide comprehensive insights into breast cancer at a molecular level. Priced at 820 AED, this test employs immunohistochemistry (IHC) techniques to detect and visualize specific proteins within tissue samples, which can be indicative of the presence and characteristics of breast cancer cells. The test is particularly valuable for determining the subtype of breast cancer, which can guide personalized treatment strategies. By utilizing digital imaging technologies, the analysis is not only accurate but also allows for the data to be easily shared and reviewed by medical professionals. This test is an essential component of modern oncology, offering patients and doctors a detailed understanding of the cancer, thereby enabling more informed decisions regarding treatment options.
The Immunohistochemistry Prostate Benign vs Malignant Panel Test is a specialized diagnostic procedure used to differentiate between benign (non-cancerous) and malignant (cancerous) prostate conditions. This test employs immunohistochemistry (IHC), a technique that uses antibodies to detect specific antigens in a sample of prostate tissue, allowing for the visualization of proteins directly involved in the pathology of prostate diseases. By examining the expression and localization of these proteins, pathologists can provide crucial information regarding the nature of the prostate condition, aiding in the accurate diagnosis and guiding treatment decisions.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and expert staff, this test offers a comprehensive analysis. The cost of the Immunohistochemistry Prostate Benign vs Malignant Panel Test is 820 AED. Given the complexity and the detailed insights it provides, this test is a valuable tool for urologists and oncologists in the management of patients with prostate conditions, helping to distinguish between conditions that may require different therapeutic approaches.
The Interleukin-6 (IL-6) Plus Panel Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to measure the levels of IL-6 in the blood. Interleukin-6 is a cytokine, a type of protein that plays a crucial role in the body's immune response, inflammation processes, and is a key indicator in the diagnosis and monitoring of various conditions, including autoimmune diseases, infections, and certain types of cancer. The test is priced at 820 AED and provides valuable insights into the patient's immune system functionality, helping healthcare professionals devise appropriate treatment strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a part of a comprehensive panel that aims to offer a detailed overview of the patient's health status, particularly in the context of immune response and inflammation.
The NAFLD - PNPLA3 and TM6SF2 Genotyping Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to assess an individual's genetic predisposition to Non-Alcoholic Fatty Liver Disease (NAFLD). This condition, characterized by excessive fat buildup in the liver not caused by alcohol use, is a growing health concern globally. The test specifically looks for variations in the PNPLA3 and TM6SF2 genes, which have been identified as significant genetic markers associated with the risk and progression of NAFLD.
By analyzing a sample of the patient's DNA, the test can identify specific mutations in these genes that may indicate a higher likelihood of developing NAFLD, thus allowing for early intervention and personalized treatment plans. This proactive approach can be crucial in managing the condition effectively, preventing its progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, or liver cancer.
Offered at a cost of 820 AED, the NAFLD - PNPLA3 and TM6SF2 Genotyping Test is an investment in personalized healthcare, enabling individuals to take informed steps towards managing their liver health based on their genetic makeup. It underscores the growing importance of genetic testing in the prevention and management of chronic diseases, offering a tailored approach to healthcare in the UAE.
